KMCRIC

Artificial intelligence is recognized as a powerful tool for enhancing research and development of novel therapeutics. Machine learning and model training can be used to efficiently inform drug and device development. If AI or machine learning can improve the success or speed of the drug development process at any point, it would have big implications down the entire chain. This is a three-track event for pharmaceutical and healthcare professionals interested in improving health outcomes through and accelerating the availability of new treatments through the use of advanced technology.